Showing results (121-130 of 190) with videos related to
Sort By:
Pageof 19
Human Molecular Genetics|July 7, 2007
Investigation of NOD1/CARD4 variation in inflammatory bowel disease using a haplotype-tagging strategyJohan Van Limbergen, Elaine R Nimmo, Richard K Russell, et al.The Journal of Physical Chemistry. B|May 6, 2016
Light Scattering Analysis of Mono- and Multi-PEGylated Bovine Serum Albumin in Solution: Role of Composition on Structure and InteractionsRachel Ferebee, Ilhem F Hakem, Amelie Koch, et al.Inflammatory Bowel Diseases|October 25, 2011
Genome-wide methylation profiling in Crohn's disease identifies altered epigenetic regulation of key host defense mechanisms including the Th17 pathwayElaine R Nimmo, James G Prendergast, Marian C Aldhous, et al.Science (New York, N.Y.)|July 25, 2020
Evaluating scenarios toward zero plastic pollutionWinnie W Y Lau, Yonathan Shiran, Richard M Bailey, et al.Inflammatory Bowel Diseases|May 12, 2011
Pediatric modification of the Montreal classification for inflammatory bowel disease: the Paris classificationArie Levine, Anne Griffiths, James Markowitz, et al.Gastroenterology|June 25, 2011
TLE1 modifies the effects of NOD2 in the pathogenesis of Crohn's diseaseElaine R Nimmo, Craig Stevens, Anne M Phillips, et al.Journal of the American Academy of Dermatology|June 5, 2018
Safety and efficacy of hydrogen peroxide topical solution, 40% (w/w), in patients with seborrheic keratoses: Results from 2 identical, randomized, double-blind, placebo-controlled, phase 3 studies (A-101-SEBK-301/302)Leslie S Baumann, Andrew Blauvelt, Zoe D Draelos, et al.Journal of Pediatric Gastroenterology and Nutrition|July 10, 2018
Switching From Originator to Biosimilar Infliximab in Paediatric Inflammatory Bowel Disease Is Feasible and UneventfulLisa Gervais, Luke L McLean, Michelle L Wilson, et al.Gastroenterology|July 25, 2014
The diagnostic approach to monogenic very early onset inflammatory bowel diseaseHolm H Uhlig, Tobias Schwerd, Sibylle Koletzko, et al.Journal of the American Academy of Dermatology|January 31, 2006
Adapalene gel 0.3% for the treatment of acne vulgaris: a multicenter, randomized, double-blind, controlled, phase III trialDiane Thiboutot, David M Pariser, Nancy Egan, et al.Pageof 19